You searched for Parkinson's - Page 19 of 20

News and Trends 26 Jun 2023

AbbVie takes step forward in Europe with migraine drug

…aims to democratize medicine by developing affordable vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the…

June 26, 2023 - 4 minutesmins - By Jim Cornall

Sector A – Z Index

…Multiple myeloma Multiple sclerosis Muscular dystrophy N Nanotechnology NASH Neurodegenerative disease Neurological disorders Next generation sequencing O Obesity omics Organoids Organs-on-chips osteoarthritis P Parkinson’s Peptides Phage therapy Precision medicine prostate…

March 24, 2023 - 0 minutesmins - By Developer

arvelle therapeutics SK Biopharmaceuticals Axovant epilepsy

More News! 18 Feb 2019

Enormous Series A to Help Bring Epilepsy Drug to Market

…Axovant’s small molecule operations. Axovant will now focus on developing the gene therapies in its pipeline, including for Parkinson’s Disease, and the rare disease GM1 gangliosidosis. While being pretty impressive,…

February 18, 2019 - 2 minutesmins - By Jonathan Smith

Best in Biotech 18 Jun 2024

5 companies spearheading the emerging biotech scene in the Balkans

…development of novel, proprietary, blood-brain barrier permeable small molecules for the treatment of neuroinflammatory and neurodegenerative diseases, such as diabetic retinopathy, demyelination and multiple sclerosis (MS), Parkinson’s and Alzheimer’s disease. …

June 18, 2024 - 6 minutesmins - By Willow Shah-Neville

News and Trends 15 Aug 2022

Aptinyx fibromyalgia drug misses endpoint

…cognitive impairment associated with Parkinson’s disease, expected in the first quarter of next year.” Study details The fibromyalgia study was a randomized, double-blind, placebo-controlled study designed to evaluate the efficacy…

August 15, 2022 - 2 minutesmins - By Jim Cornall

centogene rare diseases diagnostic ipo nasdaq

News and Trends 7 Nov 2019

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

…cancer and Parkinson’s disease. Centogen has attracted high investor interest in the past, raising a Series A round of €25M in 2017. However, according to an analyst on Seeking Alpha,…

November 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 7 Oct 2020

Investment Is Pouring Into Neuromodulation Treatments

…hearing-impaired patients, and the motor symptoms of Parkinson’s disease can sometimes be treated by electrically activating neurons deep in the brain. With advances in computational technology, these devices are getting…

October 7, 2020 - 6 minutesmins - By Helen Albert

In Depth 12 Jun 2024

Stem cell therapy: a potential cure for hearing loss?

…into brain cells and regulate dopamine levels to relieve some of the motor symptoms of Parkinson’s disease – being investigated through ongoing clinical trials – has evidenced the competence of…

June 12, 2024 - 10 minutesmins - By Roohi Mariam Peter

In Depth 1 Jun 2020

How Personal Genomics Companies Are Changing Drug Development

…thousands of patients with Parkinson’s disease in partnership with Genentech. They achieved this in record time compared to usual prospective biobanking studies requiring regulatory approval. Some companies are proposing a…

June 1, 2020 - 6 minutesmins - By Timothé Cynober

News and Trends 27 Apr 2022

Cancer Research UK Deploys €700M to Foster Oncology Startups

…number of research charities already work with scientists to develop disease treatments, such as a virtual biotech system employed by Parkinson’s UK. CRUK hopes to see more of this activity…

April 27, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 18 Jul 2023

Korro Bio and Frequency Therapeutics to merge

…programs Korro Bio’s wholly owned, early-stage pipeline targets several diseases, such as Parkinson’s disease, severe alcoholic hepatitis, amyotrophic lateral sclerosis, subsets of pain, and cardiometabolic disease. About Frequency Therapeutics Headquartered…

July 18, 2023 - 7 minutesmins - By Jim Cornall

Best in Biotech 8 Mar 2023

5 women leading the way in biotech

…for the treatment of central nervous system (CNS) disorders including therapies for schizophrenia and Parkinson’s disease. She believes that there is plenty of scope in polypharmacology, which is the use…

March 8, 2023 - 11 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

AbbVie takes step forward in Europe with migraine drug

Sector A – Z Index

Enormous Series A to Help Bring Epilepsy Drug to Market

5 companies spearheading the emerging biotech scene in the Balkans

Aptinyx fibromyalgia drug misses endpoint

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

Investment Is Pouring Into Neuromodulation Treatments

Stem cell therapy: a potential cure for hearing loss?

How Personal Genomics Companies Are Changing Drug Development

Cancer Research UK Deploys €700M to Foster Oncology Startups

Korro Bio and Frequency Therapeutics to merge

5 women leading the way in biotech

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!